Zobrazeno 1 - 10
of 24
pro vyhledávání: '"L. Fokkema"'
Autor:
A. Pinto, S. Adams, K. Ahring, H. Allen, M.F. Almeida, D. Garcia-Arenas, N. Arslan, M. Assoun, Y. Atik Altınok, D. Barrio-Carreras, A. Belanger Quintana, S.M. Bernabei, C. Bontemps, F. Boyle, G. Bruni, M. Bueno-Delgado, G. Caine, R. Carvalho, A. Chrobot, K. Chyż, B. Cochrane, C. Correia, K. Corthouts, A. Daly, S. De Leo, A. Desloovere, A. De Meyer, A. De Theux, B. Didycz, M.E. Dijsselhof, K. Dokoupil, J. Drabik, C. Dunlop, W. Eberle-Pelloth, K. Eftring, J. Ekengren, I. Errekalde, S. Evans, A. Foucart, L. Fokkema, L. François, M. French, E. Forssell, C. Gingell, C. Gonçalves, H. Gökmen Özel, A. Grimsley, G. Gugelmo, E. Gyüre, C. Heller, R. Hensler, I. Jardim, C. Joost, M. Jörg-Streller, C. Jouault, A. Jung, M. Kanthe, N. Koç, I.L. Kok, T. Kozanoğlu, B. Kumru, F. Lang, K. Lang, I. Liegeois, A. Liguori, R. Lilje, O. Ļubina, P. Manta-Vogli, D. Mayr, C. Meneses, C. Newby, U. Meyer, S. Mexia, C. Nicol, U. Och, S.M. Olivas, C. Pedrón-Giner, R. Pereira, K. Plutowska-Hoffmann, J. Purves, A. Re Dionigi, K. Reinson, M. Robert, L. Robertson, J.C. Rocha, C. Rohde, S. Rosenbaum-Fabian, A. Rossi, M. Ruiz, J. Saligova, A. Gutiérrez-Sánchez, A. Schlune, K. Schulpis, J. Serrano-Nieto, A. Skarpalezou, R. Skeath, A. Slabbert, K. Straczek, M. Giżewska, A. Terry, R. Thom, A. Tooke, J. Tuokkola, E. van Dam, T.A.M. van den Hurk, E.M.C. van der Ploeg, K. Vande Kerckhove, M. Van Driessche, A.M.J. van Wegberg, K. van Wyk, C. Vasconcelos, V. Velez García, J. Wildgoose, T. Winkler, J. Żółkowska, J. Zuvadelli, A. MacDonald
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 18, Iss , Pp 39-44 (2019)
Background: In phenylketonuria (PKU), weaning is considered more challenging when compared to feeding healthy infants. The primary aim of weaning is to gradually replace natural protein from breast milk or standard infant formula with solids containi
Externí odkaz:
https://doaj.org/article/357846d0650c409a859338dfc2ebb4fc
Autor:
A. Pinto, S. Adams, K. Ahring, H. Allen, M.F. Almeida, D. Garcia-Arenas, N. Arslan, M. Assoun, Y. Atik Altınok, D. Barrio-Carreras, A. Belanger Quintana, S.M. Bernabei, C. Bontemps, F. Boyle, G. Bruni, M. Bueno-Delgado, G. Caine, R. Carvalho, A. Chrobot, K. Chyż, B. Cochrane, C. Correia, K. Corthouts, A. Daly, S. De Leo, A. Desloovere, A. De Meyer, A. De Theux, B. Didycz, M.E. Dijsselhof, K. Dokoupil, J. Drabik, C. Dunlop, W. Eberle-Pelloth, K. Eftring, J. Ekengren, I. Errekalde, S. Evans, A. Foucart, L. Fokkema, L. François, M. French, E. Forssell, C. Gingell, C. Gonçalves, H. Gökmen Özel, A. Grimsley, G. Gugelmo, E. Gyüre, C. Heller, R. Hensler, I. Jardim, C. Joost, M. Jörg-Streller, C. Jouault, A. Jung, M. Kanthe, N. Koç, I.L. Kok, T. Kozanoğlu, B. Kumru, F. Lang, K. Lang, I. Liegeois, A. Liguori, R. Lilje, O. Ļubina, P. Manta-Vogli, D. Mayr, C. Meneses, C. Newby, U. Meyer, S. Mexia, C. Nicol, U. Och, S.M. Olivas, C. Pedrón-Giner, R. Pereira, K. Plutowska-Hoffmann, J. Purves, A. Re Dionigi, K. Reinson, M. Robert, L. Robertson, J.C. Rocha, C. Rohde, S. Rosenbaum-Fabian, A. Rossi, M. Ruiz, J. Saligova, A. Gutiérrez-Sánchez, A. Schlune, K. Schulpis, J. Serrano-Nieto, A. Skarpalezou, R. Skeath, A. Slabbert, K. Straczek, M. Giżewska, A. Terry, R. Thom, A. Tooke, J. Tuokkola, E. van Dam, T.A.M. van den Hurk, E.M.C. van der Ploeg, K. Vande Kerckhove, M. Van Driessche, A.M.J. van Wegberg, K. van Wyk, C. Vasconcelos, V. Velez García, J. Wildgoose, T. Winkler, J. Żółkowska, J. Zuvadelli, A. MacDonald
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 16, Iss , Pp 82-89 (2018)
Background: In infants with phenylketonuria (PKU), dietary management is based on lowering and titrating phenylalanine (Phe) intake from breast milk or standard infant formula in combination with a Phe-free infant formula in order to maintain blood P
Externí odkaz:
https://doaj.org/article/6dd963fe6ace47018cab1ed1c53da85c
Autor:
Karit Reinson, F. Lang, M.E. Dijsselhof, J. Żółkowska, K. Dokoupil, T.A.M. van den Hurk, W. Eberle-Pelloth, Anita MacDonald, Carolyn Dunlop, María A. Ruiz, D. Barrio-Carreras, T. Kozanoğlu, K. Vande Kerckhove, I. Jardim, Andrea Schlune, L. François, J. Wildgoose, C. Correia, A. Re Dionigi, A. De Theux, Bozena Didycz, S. De Leo, A. Skarpalezou, P. Manta-Vogli, K. Straczek, K. Chyż, A. Chrobot, H. Gokmen Ozel, Clara Vasconcelos, Maria Gizewska, Alex Pinto, Karen Corthouts, V. Velez García, M. Jörg-Streller, A. Belanger Quintana, C. Meneses, Barbara Cochrane, M.F. Almeida, K. Schulpis, C. Pedrón-Giner, R. Lilje, A. Grimsley, A.M.J. van Wegberg, T. Winkler, R. Hensler, Júlio César Rocha, G. Bruni, Louise Robertson, K. Plutowska-Hoffmann, M. Bueno-Delgado, N. Koç, Anne Daly, L. Fokkema, R. Pereira, K. Ahring, D. Garcia-Arenas, Andreas Jung, Martine Robert, S.M. Olivas, J. Serrano-Nieto, J. Saligova, S.M. Bernabei, Ulrike Och, E. Forssell, Jetta Tuokkola, R. Thom, I. Liegeois, J. Ekengren, C. Jouault, A. Gutiérrez-Sánchez, K. Lang, Camille Newby, Nur Arslan, U. Meyer, C. Joost, Moira French, C. Bontemps, H. Allen, M. Kanthe, Juri Zuvadelli, E. van Dam, A. Foucart, M. Van Driessche, I.L. Kok, A. De Meyer, J. Drabik, Carmen Rohde, Rachel Skeath, Sharon Evans, An Desloovere, C. Gingell, E.M.C. van der Ploeg, D. Mayr, E. Gyüre, Y. Atik Altınok, B. Kumru, O. Ļubina, A. Slabbert, Stefanie Rosenbaum-Fabian, G. Gugelmo, Claire Nicol, G. Caine, I. Errekalde, A. Liguori, Sandra Adams, A. Rossi, A. Tooke, R. Carvalho, J. Purves, C. Heller, M. Assoun, Carolina Gonçalves, K. Eftring, F. Boyle, A. Terry, S. Mexia, K. van Wyk
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Molecular Genetics and Metabolism Reports
Molecular Genetics and Metabolism Reports, 16, pp. 82-89
Molecular Genetics and Metabolism Reports, 16, 82. Elsevier BV
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Molecular Genetics and Metabolism Reports, 16, 82-89. Elsevier Science
Molecular Genetics and Metabolism Reports, Vol. 16, no. ?, p. 82-89 (2018)
Molecular Genetics and Metabolism Reports, 16, 82-89
Molecular Genetics And Metabolism Reports
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Molecular genetics and metabolism reports, 16, 82-89. ELSEVIER SCIENCE BV
Molecular Genetics and Metabolism Reports, Vol 16, Iss, Pp 82-89 (2018)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Molecular Genetics and Metabolism Reports
Molecular Genetics and Metabolism Reports, 16, pp. 82-89
Molecular Genetics and Metabolism Reports, 16, 82. Elsevier BV
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Molecular Genetics and Metabolism Reports, 16, 82-89. Elsevier Science
Molecular Genetics and Metabolism Reports, Vol. 16, no. ?, p. 82-89 (2018)
Molecular Genetics and Metabolism Reports, 16, 82-89
Molecular Genetics And Metabolism Reports
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Molecular genetics and metabolism reports, 16, 82-89. ELSEVIER SCIENCE BV
Molecular Genetics and Metabolism Reports, Vol 16, Iss, Pp 82-89 (2018)
WOS: 000442229500021
PubMed ID: 30101073
Background: In infants with phenylketonuria (PKU), dietary management is based on lowering and titrating phenylalanine (Phe) intake from breast milk or standard infant formula in combination with a P
PubMed ID: 30101073
Background: In infants with phenylketonuria (PKU), dietary management is based on lowering and titrating phenylalanine (Phe) intake from breast milk or standard infant formula in combination with a P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d942c40638f6ca21973930945496c0c6
Autor:
Marieke L. Fokkema, Björn Thorvinger, Tage Nilsson, Stefan James, Iwar Sjögren, Axel Åkerblom, Fredrik Calais, Bo Lagerqvist, Peter Eriksson, Bart J.G.L. de Smet, Jens Jensen, Per Albertsson
Publikováno v:
Journal of the American College of Cardiology. 61:1222-1230
Objectives The aim of this study was to describe the characteristics and outcome of all consecutive patients treated with percutaneous coronary intervention (PCI) in an unselected nationwide cohort over the past 2 decades. Background Over the last 20
Autor:
Stefan James, Bart J. G. L. de Smet, Per Tornvall, Mikael Aasa, Fredrik Calais, Peter Eriksson, Axel Åkerblom, Marieke L. Fokkema, Jens Jensen, Fredrik Scherstén, Bo Lagerqvist, Per Albertsson, Iwar Sjögren
Publikováno v:
Eurointervention, 12(3), 303-311. EUROPA EDITION
Aims: The aim of this study was to evaluate clinical outcome for different indications for PCI in an unselected, nationwide PCI population at short- and long-term follow-up.Methods and results: We evaluated clinical outcome up to six years after PCI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41a0a9af4f4b8b8bc1b1c6aa9b418c4e
https://research.rug.nl/en/publications/8d9c3ba4-4bc4-48c9-a041-613f3d644ee7
https://research.rug.nl/en/publications/8d9c3ba4-4bc4-48c9-a041-613f3d644ee7
Autor:
Iwan C. C. van der Horst, Felix Zijlstra, Bart J.G.L. de Smet, Wouter G. Wieringa, Eric Boersma, Marieke L. Fokkema
Publikováno v:
American Journal of Cardiology, 108(11), 1536-1541. EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC
American Journal of Cardiology, 108(11), 1536-1541. Elsevier Inc.
American Journal of Cardiology, 108(11), 1536-1541. Elsevier Inc.
Early reperfusion of the infarct-related coronary artery is an important issue in improvement of outcomes after ST-segment elevation myocardial infarction (STEM!). In this study, the clinical significance of total ischemic time on myocardial reperfus
Autor:
Gilles F. H. Diercks, Diny Amo, Mathijs Vogelzang, Marieke L. Fokkema, Pieter J. Vlaar, Albert J. H. Suurmeijer, Tone Svilaas, Felix Zijlstra
Publikováno v:
European Heart Journal, 30(8), 908-915. Oxford University Press
Aims We investigated the incidence and sequelae of angiographically visible distal embolization (AVDE) after primary percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction patients treated with aspirin, heparin, clopidogrel, a
Autor:
Maurizio Ferrario, Sunil V. Rao, Ken Toba, Dong-Ju Choi, Ilka Ott, Fabrice Prunier, Andrew Ludman, Hans L. Hillege, Marieke L. Fokkema, Anne M. S. Belonje, Stuart D. Katz, Peter van der Meer, Adriaan A. Voors, Dirk J. van Veldhuisen, Erik Lipsic
Publikováno v:
American Heart Journal, 168(3), 354-362.e2. MOSBY-ELSEVIER
Background Erythropoiesis-stimulating agents (ESAs) have been investigated in small studies in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Erythropoiesis-stimulating agents did
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b66f80325f315edbd717d75c31c6013
https://research.rug.nl/en/publications/1cfd5c30-647a-4760-9380-5ff9f6661165
https://research.rug.nl/en/publications/1cfd5c30-647a-4760-9380-5ff9f6661165
Publikováno v:
Circulation, 118(18), 1780-1782. LIPPINCOTT WILLIAMS & WILKINS
An acute thrombotic event resulting in total occlusion of a coronary artery is considered the principal mechanism of ST-segment elevation myocardial infarction (STEMI). De Wood et al1 were the first to show that total coronary occlusion was visible o
Autor:
Arnoud W J van 't Hof, Wiek H. van Gilst, José P.S. Henriques, Hans O. Peels, J. Wouter Jukema, Dirk J. van Veldhuisen, Sandra K. Achterhof, Peter van der Meer, Lennaert Kleijn, Adriaan A. Voors, Jurriën M. ten Berg, Hans L. Hillege, Marieke L. Fokkema, Jeroen Vos, Anne M. S. Belonje
Publikováno v:
Cardiovascular Drugs and Therapy, 27(5). Kluwer Academic Publishers
Cardiovascular Drugs and Therapy, 27(5), 433-439
fokkema, M L, Kleijn, L, van der Meer, P, Belonje, A M S, Achterhof, S K, Hillege, H L, van't Hof, A W J, Jukema, J W, Peels, H O, Henriques, J P, ten Berg, J M, Vos, J, van Gilst, W H, van Veldhuisen, D J & Voors, A A 2013, ' Long term effects of epoetin alfa in patients with ST-elevation myocardial infarction. ', Cardiovascular Drugs and Therapy, vol. 27, no. 5 . https://doi.org/10.1007/s10557-013-6470-0
Cardiovascular Drugs and Therapy, 27(5), 433-439. SPRINGER
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy, 27(5), 433-439. Kluwer Academic Publishers
Cardiovascular Drugs and Therapy, 27(5), 433-439
fokkema, M L, Kleijn, L, van der Meer, P, Belonje, A M S, Achterhof, S K, Hillege, H L, van't Hof, A W J, Jukema, J W, Peels, H O, Henriques, J P, ten Berg, J M, Vos, J, van Gilst, W H, van Veldhuisen, D J & Voors, A A 2013, ' Long term effects of epoetin alfa in patients with ST-elevation myocardial infarction. ', Cardiovascular Drugs and Therapy, vol. 27, no. 5 . https://doi.org/10.1007/s10557-013-6470-0
Cardiovascular Drugs and Therapy, 27(5), 433-439. SPRINGER
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy, 27(5), 433-439. Kluwer Academic Publishers
Purpose: The HEBE III trial showed that epoetin alfa administration in patients with a first ST-elevation myocardial infarction (STEMI) did not improve left ventricular function at 6 weeks after primary percutaneous coronary intervention (PCI). The l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23b7524ae6b14bae6d72f951f0d44bc9
https://hdl.handle.net/1887/102223
https://hdl.handle.net/1887/102223